Personalized Neoantigen Vaccine and Pembrolizumab for Advanced Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Nat. Med. 2024 Apr 07;[EPub Ahead of Print], M Yarchoan, EJ Gane, TU Marron, R Perales-Linares, J Yan, N Cooch, DH Shu, EJ Fertig, LT Kagohara, G Bartha, J Northcott, J Lyle, S Rochestie, J Peters, JT Connor, EM Jaffee, I Csiki, DB Weiner, A Perales-Puchalt, NY SardesaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.